Press release
The Peptic Ulcer Drugs Market to stumble upon digital transformation from 2020-2030, reaching US$ 47.7 Bn
Surge in the consumption of NSAIDs due to the growing prevalence of inflammatory diseases is the major factor driving the growth of the global peptic ulcer drugs market. Other trends driving growth include increasing adoption of peptic ulcer drugs over surgery, changes in disease management, prevalence of stress ulcers due to higher smoking rates, availability of affordable therapy due to improvements in the service sector, and increasing awareness toward disease management through government campaigns.
However, chronic side-effects associated with the long-term use of peptic ulcer drugs is a factor hampering the growth of the global peptic ulcer drugs market to some extent.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3704
As per PMR analysis, the global peptic ulcer drugs market is set for steady growth over the next ten years, to be valued at US$ 47.7 Bn by 2030-end.
Company Profiles:
Pfizer Inc.
Abbvie Inc.
GlaxoSmithKline plc.
AstraZeneca plc
Boehringer Ingelheim GmbH
Daewoong Pharmaceutical Co., Ltd.
Takeda Pharmaceutical
Eisai Co. Ltd.
Cadila Healthcare Ltd.
Yuhan Corporation
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/3704
Key Takeaways from Peptic Ulcer Drugs Market Study
By product, the proton pump inhibitors segment was the largest revenue generating segment in the historical years. However, revenue from the potassium-competitive acid blockers segment is expected to expand rapidly, owing to the introduction of new P-CAB drugs in the market.
Based on indication, the gastric ulcers segment is anticipated to expand at the highest CAGR of 3% over the forecast period.
On the basis of distribution channel, the hospital pharmacies segment led the global peptic ulcer drugs market, and is expected to remain the leading segment ahead too. Increasing hospitalization rates due to ulcer complications are expected to be the primary factor fuelling revenue growth of the segment over the forecast period.
North America holds the largest share in the global peptic ulcer drugs market, followed by Europe and East Asia.
Due to the worldwide COVID-19 outbreak, physician and hospital visits for non-essential treatment have reduced considerably, putting breaks on the progress of the peptic ulcer drugs market space.
"Increasing NSAID consumption is the major boosting factor for the growth of the global peptic ulcer drugs market," says a PMR analyst.
Peptic Ulcer Drugs Market: Competition Analysis
Key players operating in the global peptic ulcer drugs market are Daewoong Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited, Pfizer Inc., Abbott Laboratories, AstraZeneca Plc., Cadila Healthcare Ltd., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, and GlaxoSmithKline Pharmaceuticals Ltd. These companies are primarily focusing on strategies such as co-promotions and co-marketing of their brands to penetrate the fastest-growing emerging markets across the world.
What Else is in the Report?
Persistence Market Research offers a unique perspective and actionable insights on the peptic ulcer drugs market in its latest study, presenting historical demand assessment of 2015-2019 and projections for 2020-2030. Research of this report has been done based segmentation into product, indication, and distribution channel, across seven key regions of the world.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/3704
Access Related Reports-
Diabetic Nephropathy Market: https://www.persistencemarketresearch.com/market-research/diabetic-nephropathy-market.asp
Peripherally Inserted Central Catheters Market: https://www.persistencemarketresearch.com/market-research/peripherally-inserted-central-catheters-market.asp
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us-
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Peptic Ulcer Drugs Market to stumble upon digital transformation from 2020-2030, reaching US$ 47.7 Bn here
News-ID: 2603588 • Views: …
More Releases from Persistence Market Research
Location-Based Services (LBS) Market Set to Surpass US$150 Billion by 2033 Amid …
The global Location-Based Services (LBS) Market is projected to be valued at US$ 44.2 billion in 2026 and is expected to reach US$ 150.2 billion by 2033, expanding at a remarkable CAGR of 19.1% during 2026-2033. This strong growth trajectory reflects the rapid digitization of industries, increasing smartphone penetration, and advancements in GPS and 5G connectivity. The LBS ecosystem has evolved beyond basic navigation into a sophisticated framework powering real-time…
Cocoa Fiber Market to Reach US$696.8M by 2033 at 7.6% CAGR, Driven by Clean-Labe …
The global cocoa fiber market is poised for significant expansion over the forecast period, driven by rising demand for functional food ingredients, clean-label formulations, and sustainable by-product utilization within the cocoa processing industry. The market is expected to grow from US$ 417.3 million in 2026 to approximately US$ 696.8 million by 2033, reflecting a healthy compound annual growth rate (CAGR) of 7.6% from 2026 to 2033. This strong growth trajectory…
Non-Alcoholic Drinks Market to Hit $2,100.4B by 2033 at 8.2% CAGR on Health Tren …
The global non-alcoholic drinks market is entering a transformative growth phase, driven by evolving consumer preferences, rapid product innovation, and expanding distribution networks worldwide. The market is projected to grow from US$ 1,209.8 billion in 2026 to approximately US$ 2,100.4 billion by 2033, reflecting a robust compound annual growth rate (CAGR) of 8.2% during the forecast period from 2026 to 2033. This significant expansion underscores the increasing importance of non-alcoholic…
Bamboo Packaging Market to Reach US$ 884.5 Mn by 2033 at 6.5% CAGR Driven by Pla …
According to the latest study by Persistence Market Research, the global bamboo packaging market size is likely to be valued at US$ 569.2 million in 2026 and is expected to reach US$ 884.5 million by 2033, growing at a CAGR of 6.5% between 2026 and 2033. The growth trajectory is strongly supported by the accelerating substitution of plastic-based packaging with renewable fiber alternatives across food and beverage, cosmetics, electronics, and…
More Releases for Peptic
Obesity Fuels The Expansion Of The Peptic Ulcer Market: Powering Innovation and …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Peptic Ulcer Market Through 2025?
Recent years have witnessed consistent expansion in the market pertaining to peptic ulcers, projecting a rise from its current valuation of $4.1 billion in 2024 to $4.22 billion by 2025, reflecting a compound annual growth rate (CAGR)…
Peptic Ulcers Pipeline Insight 2025: Emerging Therapies and Clinical Trials Shap …
DelveInsight's "Peptic Ulcers - Pipeline Insight, 2025" examines over 8+ therapies in development for peptic ulcer disease, a condition affecting millions worldwide with peptic ulcer disease symptoms such as abdominal pain, bloating, nausea, and gastrointestinal bleeding. Despite widespread use of existing peptic ulcer disease treatments, including proton pump inhibitors, H2 blockers, and antibiotics for H. pylori eradication, patients with recurrent or complicated peptic ulcers continue to face significant unmet needs,…
Peptic Ulcer Market New Product Development & Latest Trends
Introduction
Peptic ulcers are open sores that develop on the inner lining of the stomach and the upper portion of the small intestine. They are primarily caused by Helicobacter pylori (H. pylori) infection, long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs), smoking, alcohol consumption, and stress-related factors. Symptoms include abdominal pain, bloating, indigestion, and, in severe cases, gastrointestinal bleeding or perforation.
Despite improved therapeutic options, peptic ulcers remain a major healthcare concern worldwide…
Key Influencer in the Peptic Ulcer Market 2025: Obesity Fuels The Expansion Of T …
What Is the Forecasted Market Size and Growth Rate for the Peptic Ulcer Market?
The peptic ulcer market has grown steadily in recent years. It will rise from $4.1 billion in 2024 to $4.24 billion in 2025, at a CAGR of 3.5%. This growth is attributed to the rising prevalence of Helicobacter pylori infection, increased use of nonsteroidal anti-inflammatory drugs (NSAIDs), changing lifestyles and dietary habits, awareness campaigns, and a focus…
Peptic Ulcer Drugs Market - Relief Within Reach: Transforming Treatment for Pept …
Newark, New Castle, USA - new report, titled Peptic Ulcer Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peptic Ulcer Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peptic Ulcer Drugs market. The report offers an overview of…
Peptic Ulcer Market Shares, Strategies, and Forecasts Analysis
Sores that develop on the lining of stomach, esophagus, and intestines are called peptic ulcers. Symptoms of peptic ulcers include vomiting, burning stomach pain, bloating, and food intolerance. These can be of three types: gastric ulcers, duodenal ulcers, and esophageal ulcers. Some of the causes of peptic ulcers are stomach infections caused by H. pylori, alcoholism, stomach cancers, usage of anti-inflammatory drugs such as aspirin, and smoking. Peptic ulcers, if…
